Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
Nuanpan Tangtavorn, Yosanan Yospaiboon, Tanapat Ratanapakorn, Suthasinee Sinawat, Thuss Sanguansak, Chavakij Bhoomibunchoo, Wipada Laovirojjanakul KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand Objective: To study the incidences of and r...
Enregistré dans:
Auteurs principaux: | Tangtavorn N, Yospaiboon Y, Ratanapakorn T, Sinawat S, Sanguansak T, Bhoomibunchoo C, Laovirojjanakul W |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b2dc6fe31f454fb080074e03705274dd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
par: Jarir At Thobari
Publié: (2021) -
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
par: Kavous Shahsavarinia, et autres
Publié: (2021) -
Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
par: Alessandra Costanza, et autres
Publié: (2021) -
Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
par: Browning DJ, et autres
Publié: (2018) -
Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions
par: Mayra Souza Botelho, et autres
Publié: (2021)